These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26545872)

  • 1. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
    Ding H; Ji X; Chen R; Ma T; Tang Z; Fen Y; Cai H
    Pulm Pharmacol Ther; 2015 Dec; 35():34-41. PubMed ID: 26545872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.
    Englert JM; Kliment CR; Ramsgaard L; Milutinovic PS; Crum L; Tobolewski JM; Oury TD
    Int J Clin Exp Pathol; 2011 Mar; 4(3):241-54. PubMed ID: 21487520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of receptor for advanced glycation end product‑specific small interfering RNAs on the development of hepatic fibrosis in primary rat hepatic stellate cells.
    Xia JR; Chen TT; Li WD; Lu FL; Liu J; Cai XG; Lu Q; Yang CP
    Mol Med Rep; 2015 Jul; 12(1):569-74. PubMed ID: 25673150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
    Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
    Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
    Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
    Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
    Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
    Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified canonical transforming growth factor-β signalling
    Sibinska Z; Tian X; Korfei M; Kojonazarov B; Kolb JS; Klepetko W; Kosanovic D; Wygrecka M; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Guenther A; Schermuly RT
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
    Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
    Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.
    Weng CM; Li Q; Chen KJ; Xu CX; Deng MS; Li T; Zhang DD; Duan ZX; Chen ZQ; Li GH; Chen J; Wang JM
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model.
    Piao C; Zhuang C; Ko MK; Hwang DW; Lee M
    J Drug Target; 2022 Aug; 30(7):792-799. PubMed ID: 35451894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sesamin on airway fibrosis in vitro and in vivo.
    Lin CH; Shen ML; Kao ST; Wu DC
    Int Immunopharmacol; 2014 Sep; 22(1):141-50. PubMed ID: 24978608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
    J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.